Latest / The Vox Markets Podcast
2404: MedPal AI Launches New Health — £1.3m Push Into GLP-1
MedPal AI (AIM: MPAL) launches New Health, a standalone GLP-1 sub-brand backed by £1.3 million of marketing, ahead of expected UK approval of Novo Nordisk’s oral Wegovy. CEO Jason Drummond on the strategy, the market, and the unit economics behind it.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.